COVID-19 Impact on Global Ketorolac Tromethamine Market Insights, Forecast to 2026
Ketorolac Tromethamine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ketorolac Tromethamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ketorolac Tromethamine market is segmented into
The Ketorolac Tromethamine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ketorolac Tromethamine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ketorolac Tromethamine Market Share Analysis
Ketorolac Tromethamine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ketorolac Tromethamine business, the date to enter into the Ketorolac Tromethamine market, Ketorolac Tromethamine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Ketorolac Tromethamine market is segmented into
- Injection
- Ophthalmic
- Nasal
- Oral tablet
- Short-term treatment of pain
- Ophthalmic Surgery
The Ketorolac Tromethamine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ketorolac Tromethamine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ketorolac Tromethamine Market Share Analysis
Ketorolac Tromethamine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ketorolac Tromethamine business, the date to enter into the Ketorolac Tromethamine market, Ketorolac Tromethamine product introduction, recent developments, etc.
The major vendors covered:
- Pfizer
- Omeros Corporation
- Egalet US Inc.
- Allergan
- Dr. Reddy’s Laboratories
- Teva
- Mylan
- West Ward Pharmaceuticals
- Fresenius Kabi
- Apotex
- Sandoz
- Amphastar Pharmaceuticals
- Gland Pharma Limited
- Akorn
- Sun Pharmaceutical
- Sagent Pharmaceuticals
- Aurobindo Pharma
1 STUDY COVERAGE
1.1 Ketorolac Tromethamine Product Introduction
1.2 Market Segments
1.3 Key Ketorolac Tromethamine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ketorolac Tromethamine Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Ophthalmic
1.4.4 Nasal
1.4.5 Oral tablet
1.5 Market by Application
1.5.1 Global Ketorolac Tromethamine Market Size Growth Rate by Application
1.5.2 Short-term treatment of pain
1.5.3 Ophthalmic Surgery
1.6 Coronavirus Disease 2019 (Covid-19): Ketorolac Tromethamine Industry Impact
1.6.1 How the Covid-19 is Affecting the Ketorolac Tromethamine Industry
1.6.1.1 Ketorolac Tromethamine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ketorolac Tromethamine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ketorolac Tromethamine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ketorolac Tromethamine Market Size Estimates and Forecasts
2.1.1 Global Ketorolac Tromethamine Revenue 2015-2026
2.1.2 Global Ketorolac Tromethamine Sales 2015-2026
2.2 Ketorolac Tromethamine Market Size by Region: 2020 Versus 2026
2.2.1 Global Ketorolac Tromethamine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ketorolac Tromethamine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL KETOROLAC TROMETHAMINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ketorolac Tromethamine Sales by Manufacturers
3.1.1 Ketorolac Tromethamine Sales by Manufacturers (2015-2020)
3.1.2 Ketorolac Tromethamine Sales Market Share by Manufacturers (2015-2020)
3.2 Ketorolac Tromethamine Revenue by Manufacturers
3.2.1 Ketorolac Tromethamine Revenue by Manufacturers (2015-2020)
3.2.2 Ketorolac Tromethamine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ketorolac Tromethamine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ketorolac Tromethamine Revenue in 2019
3.2.5 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ketorolac Tromethamine Price by Manufacturers
3.4 Ketorolac Tromethamine Manufacturing Base Distribution, Product Types
3.4.1 Ketorolac Tromethamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ketorolac Tromethamine Product Type
3.4.3 Date of International Manufacturers Enter into Ketorolac Tromethamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ketorolac Tromethamine Market Size by Type (2015-2020)
4.1.1 Global Ketorolac Tromethamine Sales by Type (2015-2020)
4.1.2 Global Ketorolac Tromethamine Revenue by Type (2015-2020)
4.1.3 Ketorolac Tromethamine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ketorolac Tromethamine Market Size Forecast by Type (2021-2026)
4.2.1 Global Ketorolac Tromethamine Sales Forecast by Type (2021-2026)
4.2.2 Global Ketorolac Tromethamine Revenue Forecast by Type (2021-2026)
4.2.3 Ketorolac Tromethamine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ketorolac Tromethamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ketorolac Tromethamine Market Size by Application (2015-2020)
5.1.1 Global Ketorolac Tromethamine Sales by Application (2015-2020)
5.1.2 Global Ketorolac Tromethamine Revenue by Application (2015-2020)
5.1.3 Ketorolac Tromethamine Price by Application (2015-2020)
5.2 Ketorolac Tromethamine Market Size Forecast by Application (2021-2026)
5.2.1 Global Ketorolac Tromethamine Sales Forecast by Application (2021-2026)
5.2.2 Global Ketorolac Tromethamine Revenue Forecast by Application (2021-2026)
5.2.3 Global Ketorolac Tromethamine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ketorolac Tromethamine by Country
6.1.1 North America Ketorolac Tromethamine Sales by Country
6.1.2 North America Ketorolac Tromethamine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ketorolac Tromethamine Market Facts & Figures by Type
6.3 North America Ketorolac Tromethamine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ketorolac Tromethamine by Country
7.1.1 Europe Ketorolac Tromethamine Sales by Country
7.1.2 Europe Ketorolac Tromethamine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ketorolac Tromethamine Market Facts & Figures by Type
7.3 Europe Ketorolac Tromethamine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ketorolac Tromethamine by Region
8.1.1 Asia Pacific Ketorolac Tromethamine Sales by Region
8.1.2 Asia Pacific Ketorolac Tromethamine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Type
8.3 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ketorolac Tromethamine by Country
9.1.1 Latin America Ketorolac Tromethamine Sales by Country
9.1.2 Latin America Ketorolac Tromethamine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ketorolac Tromethamine Market Facts & Figures by Type
9.3 Central & South America Ketorolac Tromethamine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ketorolac Tromethamine by Country
10.1.1 Middle East and Africa Ketorolac Tromethamine Sales by Country
10.1.2 Middle East and Africa Ketorolac Tromethamine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Type
10.3 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Ketorolac Tromethamine Products Offered
11.1.5 Pfizer Recent Development
11.2 Omeros Corporation
11.2.1 Omeros Corporation Corporation Information
11.2.2 Omeros Corporation Description, Business Overview and Total Revenue
11.2.3 Omeros Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
11.2.5 Omeros Corporation Recent Development
11.3 Egalet US Inc.
11.3.1 Egalet US Inc. Corporation Information
11.3.2 Egalet US Inc. Description, Business Overview and Total Revenue
11.3.3 Egalet US Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
11.3.5 Egalet US Inc. Recent Development
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Description, Business Overview and Total Revenue
11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan Ketorolac Tromethamine Products Offered
11.4.5 Allergan Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Corporation Information
11.5.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
11.5.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Products Offered
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Description, Business Overview and Total Revenue
11.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Ketorolac Tromethamine Products Offered
11.6.5 Teva Recent Development
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Description, Business Overview and Total Revenue
11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mylan Ketorolac Tromethamine Products Offered
11.7.5 Mylan Recent Development
11.8 West Ward Pharmaceuticals
11.8.1 West Ward Pharmaceuticals Corporation Information
11.8.2 West Ward Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 West Ward Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
11.8.5 West Ward Pharmaceuticals Recent Development
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Corporation Information
11.9.2 Fresenius Kabi Description, Business Overview and Total Revenue
11.9.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
11.9.5 Fresenius Kabi Recent Development
11.10 Apotex
11.10.1 Apotex Corporation Information
11.10.2 Apotex Description, Business Overview and Total Revenue
11.10.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Apotex Ketorolac Tromethamine Products Offered
11.10.5 Apotex Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Ketorolac Tromethamine Products Offered
11.1.5 Pfizer Recent Development
11.12 Amphastar Pharmaceuticals
11.12.1 Amphastar Pharmaceuticals Corporation Information
11.12.2 Amphastar Pharmaceuticals Description, Business Overview and Total Revenue
11.12.3 Amphastar Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Amphastar Pharmaceuticals Products Offered
11.12.5 Amphastar Pharmaceuticals Recent Development
11.13 Gland Pharma Limited
11.13.1 Gland Pharma Limited Corporation Information
11.13.2 Gland Pharma Limited Description, Business Overview and Total Revenue
11.13.3 Gland Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Gland Pharma Limited Products Offered
11.13.5 Gland Pharma Limited Recent Development
11.14 Akorn
11.14.1 Akorn Corporation Information
11.14.2 Akorn Description, Business Overview and Total Revenue
11.14.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Akorn Products Offered
11.14.5 Akorn Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Corporation Information
11.15.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sun Pharmaceutical Products Offered
11.15.5 Sun Pharmaceutical Recent Development
11.16 Sagent Pharmaceuticals
11.16.1 Sagent Pharmaceuticals Corporation Information
11.16.2 Sagent Pharmaceuticals Description, Business Overview and Total Revenue
11.16.3 Sagent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sagent Pharmaceuticals Products Offered
11.16.5 Sagent Pharmaceuticals Recent Development
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Corporation Information
11.17.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.17.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Aurobindo Pharma Products Offered
11.17.5 Aurobindo Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ketorolac Tromethamine Market Estimates and Projections by Region
12.1.1 Global Ketorolac Tromethamine Sales Forecast by Regions 2021-2026
12.1.2 Global Ketorolac Tromethamine Revenue Forecast by Regions 2021-2026
12.2 North America Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.2.1 North America: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.2.2 North America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.2.3 North America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.3 Europe Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.3.1 Europe: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.3.2 Europe: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.3.3 Europe: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ketorolac Tromethamine Market Size Forecast by Region (2021-2026)
12.5 Latin America Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.5.1 Latin America: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.5.2 Latin America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.5.3 Latin America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ketorolac Tromethamine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ketorolac Tromethamine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Ketorolac Tromethamine Product Introduction
1.2 Market Segments
1.3 Key Ketorolac Tromethamine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ketorolac Tromethamine Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Ophthalmic
1.4.4 Nasal
1.4.5 Oral tablet
1.5 Market by Application
1.5.1 Global Ketorolac Tromethamine Market Size Growth Rate by Application
1.5.2 Short-term treatment of pain
1.5.3 Ophthalmic Surgery
1.6 Coronavirus Disease 2019 (Covid-19): Ketorolac Tromethamine Industry Impact
1.6.1 How the Covid-19 is Affecting the Ketorolac Tromethamine Industry
1.6.1.1 Ketorolac Tromethamine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ketorolac Tromethamine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ketorolac Tromethamine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ketorolac Tromethamine Market Size Estimates and Forecasts
2.1.1 Global Ketorolac Tromethamine Revenue 2015-2026
2.1.2 Global Ketorolac Tromethamine Sales 2015-2026
2.2 Ketorolac Tromethamine Market Size by Region: 2020 Versus 2026
2.2.1 Global Ketorolac Tromethamine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ketorolac Tromethamine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL KETOROLAC TROMETHAMINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ketorolac Tromethamine Sales by Manufacturers
3.1.1 Ketorolac Tromethamine Sales by Manufacturers (2015-2020)
3.1.2 Ketorolac Tromethamine Sales Market Share by Manufacturers (2015-2020)
3.2 Ketorolac Tromethamine Revenue by Manufacturers
3.2.1 Ketorolac Tromethamine Revenue by Manufacturers (2015-2020)
3.2.2 Ketorolac Tromethamine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ketorolac Tromethamine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ketorolac Tromethamine Revenue in 2019
3.2.5 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ketorolac Tromethamine Price by Manufacturers
3.4 Ketorolac Tromethamine Manufacturing Base Distribution, Product Types
3.4.1 Ketorolac Tromethamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ketorolac Tromethamine Product Type
3.4.3 Date of International Manufacturers Enter into Ketorolac Tromethamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ketorolac Tromethamine Market Size by Type (2015-2020)
4.1.1 Global Ketorolac Tromethamine Sales by Type (2015-2020)
4.1.2 Global Ketorolac Tromethamine Revenue by Type (2015-2020)
4.1.3 Ketorolac Tromethamine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ketorolac Tromethamine Market Size Forecast by Type (2021-2026)
4.2.1 Global Ketorolac Tromethamine Sales Forecast by Type (2021-2026)
4.2.2 Global Ketorolac Tromethamine Revenue Forecast by Type (2021-2026)
4.2.3 Ketorolac Tromethamine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ketorolac Tromethamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ketorolac Tromethamine Market Size by Application (2015-2020)
5.1.1 Global Ketorolac Tromethamine Sales by Application (2015-2020)
5.1.2 Global Ketorolac Tromethamine Revenue by Application (2015-2020)
5.1.3 Ketorolac Tromethamine Price by Application (2015-2020)
5.2 Ketorolac Tromethamine Market Size Forecast by Application (2021-2026)
5.2.1 Global Ketorolac Tromethamine Sales Forecast by Application (2021-2026)
5.2.2 Global Ketorolac Tromethamine Revenue Forecast by Application (2021-2026)
5.2.3 Global Ketorolac Tromethamine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ketorolac Tromethamine by Country
6.1.1 North America Ketorolac Tromethamine Sales by Country
6.1.2 North America Ketorolac Tromethamine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ketorolac Tromethamine Market Facts & Figures by Type
6.3 North America Ketorolac Tromethamine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ketorolac Tromethamine by Country
7.1.1 Europe Ketorolac Tromethamine Sales by Country
7.1.2 Europe Ketorolac Tromethamine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ketorolac Tromethamine Market Facts & Figures by Type
7.3 Europe Ketorolac Tromethamine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ketorolac Tromethamine by Region
8.1.1 Asia Pacific Ketorolac Tromethamine Sales by Region
8.1.2 Asia Pacific Ketorolac Tromethamine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Type
8.3 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ketorolac Tromethamine by Country
9.1.1 Latin America Ketorolac Tromethamine Sales by Country
9.1.2 Latin America Ketorolac Tromethamine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ketorolac Tromethamine Market Facts & Figures by Type
9.3 Central & South America Ketorolac Tromethamine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ketorolac Tromethamine by Country
10.1.1 Middle East and Africa Ketorolac Tromethamine Sales by Country
10.1.2 Middle East and Africa Ketorolac Tromethamine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Type
10.3 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Ketorolac Tromethamine Products Offered
11.1.5 Pfizer Recent Development
11.2 Omeros Corporation
11.2.1 Omeros Corporation Corporation Information
11.2.2 Omeros Corporation Description, Business Overview and Total Revenue
11.2.3 Omeros Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
11.2.5 Omeros Corporation Recent Development
11.3 Egalet US Inc.
11.3.1 Egalet US Inc. Corporation Information
11.3.2 Egalet US Inc. Description, Business Overview and Total Revenue
11.3.3 Egalet US Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
11.3.5 Egalet US Inc. Recent Development
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Description, Business Overview and Total Revenue
11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan Ketorolac Tromethamine Products Offered
11.4.5 Allergan Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Corporation Information
11.5.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
11.5.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Products Offered
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Description, Business Overview and Total Revenue
11.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Ketorolac Tromethamine Products Offered
11.6.5 Teva Recent Development
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Description, Business Overview and Total Revenue
11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mylan Ketorolac Tromethamine Products Offered
11.7.5 Mylan Recent Development
11.8 West Ward Pharmaceuticals
11.8.1 West Ward Pharmaceuticals Corporation Information
11.8.2 West Ward Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 West Ward Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
11.8.5 West Ward Pharmaceuticals Recent Development
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Corporation Information
11.9.2 Fresenius Kabi Description, Business Overview and Total Revenue
11.9.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
11.9.5 Fresenius Kabi Recent Development
11.10 Apotex
11.10.1 Apotex Corporation Information
11.10.2 Apotex Description, Business Overview and Total Revenue
11.10.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Apotex Ketorolac Tromethamine Products Offered
11.10.5 Apotex Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Ketorolac Tromethamine Products Offered
11.1.5 Pfizer Recent Development
11.12 Amphastar Pharmaceuticals
11.12.1 Amphastar Pharmaceuticals Corporation Information
11.12.2 Amphastar Pharmaceuticals Description, Business Overview and Total Revenue
11.12.3 Amphastar Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Amphastar Pharmaceuticals Products Offered
11.12.5 Amphastar Pharmaceuticals Recent Development
11.13 Gland Pharma Limited
11.13.1 Gland Pharma Limited Corporation Information
11.13.2 Gland Pharma Limited Description, Business Overview and Total Revenue
11.13.3 Gland Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Gland Pharma Limited Products Offered
11.13.5 Gland Pharma Limited Recent Development
11.14 Akorn
11.14.1 Akorn Corporation Information
11.14.2 Akorn Description, Business Overview and Total Revenue
11.14.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Akorn Products Offered
11.14.5 Akorn Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Corporation Information
11.15.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sun Pharmaceutical Products Offered
11.15.5 Sun Pharmaceutical Recent Development
11.16 Sagent Pharmaceuticals
11.16.1 Sagent Pharmaceuticals Corporation Information
11.16.2 Sagent Pharmaceuticals Description, Business Overview and Total Revenue
11.16.3 Sagent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sagent Pharmaceuticals Products Offered
11.16.5 Sagent Pharmaceuticals Recent Development
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Corporation Information
11.17.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.17.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Aurobindo Pharma Products Offered
11.17.5 Aurobindo Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ketorolac Tromethamine Market Estimates and Projections by Region
12.1.1 Global Ketorolac Tromethamine Sales Forecast by Regions 2021-2026
12.1.2 Global Ketorolac Tromethamine Revenue Forecast by Regions 2021-2026
12.2 North America Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.2.1 North America: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.2.2 North America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.2.3 North America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.3 Europe Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.3.1 Europe: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.3.2 Europe: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.3.3 Europe: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ketorolac Tromethamine Market Size Forecast by Region (2021-2026)
12.5 Latin America Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.5.1 Latin America: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.5.2 Latin America: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.5.3 Latin America: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ketorolac Tromethamine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ketorolac Tromethamine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ketorolac Tromethamine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ketorolac Tromethamine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ketorolac Tromethamine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ketorolac Tromethamine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Ketorolac Tromethamine Market Segments
Table 2. Ranking of Global Top Ketorolac Tromethamine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ketorolac Tromethamine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Ophthalmic
Table 6. Major Manufacturers of Nasal
Table 7. Major Manufacturers of Oral tablet
Table 8. COVID-19 Impact Global Market: (Four Ketorolac Tromethamine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Ketorolac Tromethamine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Ketorolac Tromethamine Players to Combat Covid-19 Impact
Table 13. Global Ketorolac Tromethamine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Ketorolac Tromethamine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Ketorolac Tromethamine Sales by Regions 2015-2020 (K Units)
Table 16. Global Ketorolac Tromethamine Sales Market Share by Regions (2015-2020)
Table 17. Global Ketorolac Tromethamine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Ketorolac Tromethamine Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Ketorolac Tromethamine Sales Share by Manufacturers (2015-2020)
Table 20. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac Tromethamine as of 2019)
Table 22. Ketorolac Tromethamine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Ketorolac Tromethamine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Ketorolac Tromethamine Price (2015-2020) (USD/Unit)
Table 25. Ketorolac Tromethamine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Ketorolac Tromethamine Product Type
Table 27. Date of International Manufacturers Enter into Ketorolac Tromethamine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 30. Global Ketorolac Tromethamine Sales Share by Type (2015-2020)
Table 31. Global Ketorolac Tromethamine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Ketorolac Tromethamine Revenue Share by Type (2015-2020)
Table 33. Ketorolac Tromethamine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 35. Global Ketorolac Tromethamine Sales Share by Application (2015-2020)
Table 36. North America Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 37. North America Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 38. North America Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 40. North America Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 41. North America Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 42. North America Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 43. North America Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 44. Europe Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 45. Europe Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 46. Europe Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 48. Europe Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 49. Europe Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 50. Europe Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 51. Europe Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Ketorolac Tromethamine Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Ketorolac Tromethamine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 60. Latin America Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 61. Latin America Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 65. Latin America Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 66. Latin America Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 67. Latin America Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 76. Pfizer Corporation Information
Table 77. Pfizer Description and Major Businesses
Table 78. Pfizer Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Pfizer Product
Table 80. Pfizer Recent Development
Table 81. Omeros Corporation Corporation Information
Table 82. Omeros Corporation Description and Major Businesses
Table 83. Omeros Corporation Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Omeros Corporation Product
Table 85. Omeros Corporation Recent Development
Table 86. Egalet US Inc. Corporation Information
Table 87. Egalet US Inc. Description and Major Businesses
Table 88. Egalet US Inc. Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Egalet US Inc. Product
Table 90. Egalet US Inc. Recent Development
Table 91. Allergan Corporation Information
Table 92. Allergan Description and Major Businesses
Table 93. Allergan Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Allergan Product
Table 95. Allergan Recent Development
Table 96. Dr. Reddy’s Laboratories Corporation Information
Table 97. Dr. Reddy’s Laboratories Description and Major Businesses
Table 98. Dr. Reddy’s Laboratories Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Dr. Reddy’s Laboratories Product
Table 100. Dr. Reddy’s Laboratories Recent Development
Table 101. Teva Corporation Information
Table 102. Teva Description and Major Businesses
Table 103. Teva Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Teva Product
Table 105. Teva Recent Development
Table 106. Mylan Corporation Information
Table 107. Mylan Description and Major Businesses
Table 108. Mylan Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mylan Product
Table 110. Mylan Recent Development
Table 111. West Ward Pharmaceuticals Corporation Information
Table 112. West Ward Pharmaceuticals Description and Major Businesses
Table 113. West Ward Pharmaceuticals Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. West Ward Pharmaceuticals Product
Table 115. West Ward Pharmaceuticals Recent Development
Table 116. Fresenius Kabi Corporation Information
Table 117. Fresenius Kabi Description and Major Businesses
Table 118. Fresenius Kabi Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Fresenius Kabi Product
Table 120. Fresenius Kabi Recent Development
Table 121. Apotex Corporation Information
Table 122. Apotex Description and Major Businesses
Table 123. Apotex Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Apotex Product
Table 125. Apotex Recent Development
Table 126. Sandoz Corporation Information
Table 127. Sandoz Description and Major Businesses
Table 128. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Sandoz Product
Table 130. Sandoz Recent Development
Table 131. Amphastar Pharmaceuticals Corporation Information
Table 132. Amphastar Pharmaceuticals Description and Major Businesses
Table 133. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Amphastar Pharmaceuticals Product
Table 135. Amphastar Pharmaceuticals Recent Development
Table 136. Gland Pharma Limited Corporation Information
Table 137. Gland Pharma Limited Description and Major Businesses
Table 138. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Gland Pharma Limited Product
Table 140. Gland Pharma Limited Recent Development
Table 141. Akorn Corporation Information
Table 142. Akorn Description and Major Businesses
Table 143. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Akorn Product
Table 145. Akorn Recent Development
Table 146. Sun Pharmaceutical Corporation Information
Table 147. Sun Pharmaceutical Description and Major Businesses
Table 148. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Sun Pharmaceutical Product
Table 150. Sun Pharmaceutical Recent Development
Table 151. Sagent Pharmaceuticals Corporation Information
Table 152. Sagent Pharmaceuticals Description and Major Businesses
Table 153. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. Sagent Pharmaceuticals Product
Table 155. Sagent Pharmaceuticals Recent Development
Table 156. Aurobindo Pharma Corporation Information
Table 157. Aurobindo Pharma Description and Major Businesses
Table 158. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 159. Aurobindo Pharma Product
Table 160. Aurobindo Pharma Recent Development
Table 161. Global Ketorolac Tromethamine Sales Forecast by Regions (2021-2026) (K Units)
Table 162. Global Ketorolac Tromethamine Sales Market Share Forecast by Regions (2021-2026)
Table 163. Global Ketorolac Tromethamine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 164. Global Ketorolac Tromethamine Revenue Market Share Forecast by Regions (2021-2026)
Table 165. North America: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 166. North America: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Europe: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 168. Europe: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Asia Pacific: Ketorolac Tromethamine Sales Forecast by Region (2021-2026) (K Units)
Table 170. Asia Pacific: Ketorolac Tromethamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 171. Latin America: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 172. Latin America: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Middle East and Africa: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 174. Middle East and Africa: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 176. Key Challenges
Table 177. Market Risks
Table 178. Main Points Interviewed from Key Ketorolac Tromethamine Players
Table 179. Ketorolac Tromethamine Customers List
Table 180. Ketorolac Tromethamine Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
Table 1. Ketorolac Tromethamine Market Segments
Table 2. Ranking of Global Top Ketorolac Tromethamine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ketorolac Tromethamine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Ophthalmic
Table 6. Major Manufacturers of Nasal
Table 7. Major Manufacturers of Oral tablet
Table 8. COVID-19 Impact Global Market: (Four Ketorolac Tromethamine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Ketorolac Tromethamine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Ketorolac Tromethamine Players to Combat Covid-19 Impact
Table 13. Global Ketorolac Tromethamine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Ketorolac Tromethamine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Ketorolac Tromethamine Sales by Regions 2015-2020 (K Units)
Table 16. Global Ketorolac Tromethamine Sales Market Share by Regions (2015-2020)
Table 17. Global Ketorolac Tromethamine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Ketorolac Tromethamine Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Ketorolac Tromethamine Sales Share by Manufacturers (2015-2020)
Table 20. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac Tromethamine as of 2019)
Table 22. Ketorolac Tromethamine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Ketorolac Tromethamine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Ketorolac Tromethamine Price (2015-2020) (USD/Unit)
Table 25. Ketorolac Tromethamine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Ketorolac Tromethamine Product Type
Table 27. Date of International Manufacturers Enter into Ketorolac Tromethamine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 30. Global Ketorolac Tromethamine Sales Share by Type (2015-2020)
Table 31. Global Ketorolac Tromethamine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Ketorolac Tromethamine Revenue Share by Type (2015-2020)
Table 33. Ketorolac Tromethamine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 35. Global Ketorolac Tromethamine Sales Share by Application (2015-2020)
Table 36. North America Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 37. North America Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 38. North America Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 40. North America Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 41. North America Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 42. North America Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 43. North America Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 44. Europe Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 45. Europe Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 46. Europe Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 48. Europe Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 49. Europe Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 50. Europe Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 51. Europe Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Ketorolac Tromethamine Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Ketorolac Tromethamine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 60. Latin America Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 61. Latin America Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 65. Latin America Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 66. Latin America Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 67. Latin America Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Ketorolac Tromethamine Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ketorolac Tromethamine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Ketorolac Tromethamine Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Ketorolac Tromethamine Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Table 76. Pfizer Corporation Information
Table 77. Pfizer Description and Major Businesses
Table 78. Pfizer Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Pfizer Product
Table 80. Pfizer Recent Development
Table 81. Omeros Corporation Corporation Information
Table 82. Omeros Corporation Description and Major Businesses
Table 83. Omeros Corporation Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Omeros Corporation Product
Table 85. Omeros Corporation Recent Development
Table 86. Egalet US Inc. Corporation Information
Table 87. Egalet US Inc. Description and Major Businesses
Table 88. Egalet US Inc. Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Egalet US Inc. Product
Table 90. Egalet US Inc. Recent Development
Table 91. Allergan Corporation Information
Table 92. Allergan Description and Major Businesses
Table 93. Allergan Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Allergan Product
Table 95. Allergan Recent Development
Table 96. Dr. Reddy’s Laboratories Corporation Information
Table 97. Dr. Reddy’s Laboratories Description and Major Businesses
Table 98. Dr. Reddy’s Laboratories Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Dr. Reddy’s Laboratories Product
Table 100. Dr. Reddy’s Laboratories Recent Development
Table 101. Teva Corporation Information
Table 102. Teva Description and Major Businesses
Table 103. Teva Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Teva Product
Table 105. Teva Recent Development
Table 106. Mylan Corporation Information
Table 107. Mylan Description and Major Businesses
Table 108. Mylan Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mylan Product
Table 110. Mylan Recent Development
Table 111. West Ward Pharmaceuticals Corporation Information
Table 112. West Ward Pharmaceuticals Description and Major Businesses
Table 113. West Ward Pharmaceuticals Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. West Ward Pharmaceuticals Product
Table 115. West Ward Pharmaceuticals Recent Development
Table 116. Fresenius Kabi Corporation Information
Table 117. Fresenius Kabi Description and Major Businesses
Table 118. Fresenius Kabi Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Fresenius Kabi Product
Table 120. Fresenius Kabi Recent Development
Table 121. Apotex Corporation Information
Table 122. Apotex Description and Major Businesses
Table 123. Apotex Ketorolac Tromethamine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Apotex Product
Table 125. Apotex Recent Development
Table 126. Sandoz Corporation Information
Table 127. Sandoz Description and Major Businesses
Table 128. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Sandoz Product
Table 130. Sandoz Recent Development
Table 131. Amphastar Pharmaceuticals Corporation Information
Table 132. Amphastar Pharmaceuticals Description and Major Businesses
Table 133. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Amphastar Pharmaceuticals Product
Table 135. Amphastar Pharmaceuticals Recent Development
Table 136. Gland Pharma Limited Corporation Information
Table 137. Gland Pharma Limited Description and Major Businesses
Table 138. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Gland Pharma Limited Product
Table 140. Gland Pharma Limited Recent Development
Table 141. Akorn Corporation Information
Table 142. Akorn Description and Major Businesses
Table 143. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Akorn Product
Table 145. Akorn Recent Development
Table 146. Sun Pharmaceutical Corporation Information
Table 147. Sun Pharmaceutical Description and Major Businesses
Table 148. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Sun Pharmaceutical Product
Table 150. Sun Pharmaceutical Recent Development
Table 151. Sagent Pharmaceuticals Corporation Information
Table 152. Sagent Pharmaceuticals Description and Major Businesses
Table 153. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. Sagent Pharmaceuticals Product
Table 155. Sagent Pharmaceuticals Recent Development
Table 156. Aurobindo Pharma Corporation Information
Table 157. Aurobindo Pharma Description and Major Businesses
Table 158. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 159. Aurobindo Pharma Product
Table 160. Aurobindo Pharma Recent Development
Table 161. Global Ketorolac Tromethamine Sales Forecast by Regions (2021-2026) (K Units)
Table 162. Global Ketorolac Tromethamine Sales Market Share Forecast by Regions (2021-2026)
Table 163. Global Ketorolac Tromethamine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 164. Global Ketorolac Tromethamine Revenue Market Share Forecast by Regions (2021-2026)
Table 165. North America: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 166. North America: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Europe: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 168. Europe: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Asia Pacific: Ketorolac Tromethamine Sales Forecast by Region (2021-2026) (K Units)
Table 170. Asia Pacific: Ketorolac Tromethamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 171. Latin America: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 172. Latin America: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Middle East and Africa: Ketorolac Tromethamine Sales Forecast by Country (2021-2026) (K Units)
Table 174. Middle East and Africa: Ketorolac Tromethamine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 176. Key Challenges
Table 177. Market Risks
Table 178. Main Points Interviewed from Key Ketorolac Tromethamine Players
Table 179. Ketorolac Tromethamine Customers List
Table 180. Ketorolac Tromethamine Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Ketorolac Tromethamine Product Picture
Figure 2. Global Ketorolac Tromethamine Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Ophthalmic Product Picture
Figure 5. Nasal Product Picture
Figure 6. Oral tablet Product Picture
Figure 7. Global Ketorolac Tromethamine Sales Market Share by Application in 2020 & 2026
Figure 8. Short-term treatment of pain
Figure 9. Ophthalmic Surgery
Figure 10. Ketorolac Tromethamine Report Years Considered
Figure 11. Global Ketorolac Tromethamine Market Size 2015-2026 (US$ Million)
Figure 12. Global Ketorolac Tromethamine Sales 2015-2026 (K Units)
Figure 13. Global Ketorolac Tromethamine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ketorolac Tromethamine Sales Market Share by Region (2015-2020)
Figure 15. Global Ketorolac Tromethamine Sales Market Share by Region in 2019
Figure 16. Global Ketorolac Tromethamine Revenue Market Share by Region (2015-2020)
Figure 17. Global Ketorolac Tromethamine Revenue Market Share by Region in 2019
Figure 18. Global Ketorolac Tromethamine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ketorolac Tromethamine Revenue in 2019
Figure 20. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Figure 22. Global Ketorolac Tromethamine Sales Market Share by Type in 2019
Figure 23. Global Ketorolac Tromethamine Revenue Market Share by Type (2015-2020)
Figure 24. Global Ketorolac Tromethamine Revenue Market Share by Type in 2019
Figure 25. Global Ketorolac Tromethamine Market Share by Price Range (2015-2020)
Figure 26. Global Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Figure 27. Global Ketorolac Tromethamine Sales Market Share by Application in 2019
Figure 28. Global Ketorolac Tromethamine Revenue Market Share by Application (2015-2020)
Figure 29. Global Ketorolac Tromethamine Revenue Market Share by Application in 2019
Figure 30. North America Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 33. North America Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 34. U.S. Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ketorolac Tromethamine Market Share by Type in 2019
Figure 39. North America Ketorolac Tromethamine Market Share by Application in 2019
Figure 40. Europe Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 43. Europe Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 44. Germany Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ketorolac Tromethamine Market Share by Type in 2019
Figure 55. Europe Ketorolac Tromethamine Market Share by Application in 2019
Figure 56. Asia Pacific Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region in 2019
Figure 60. China Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ketorolac Tromethamine Market Share by Type in 2019
Figure 83. Asia Pacific Ketorolac Tromethamine Market Share by Application in 2019
Figure 84. Latin America Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 87. Latin America Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 88. Mexico Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ketorolac Tromethamine Market Share by Type in 2019
Figure 95. Latin America Ketorolac Tromethamine Market Share by Application in 2019
Figure 96. Middle East and Africa Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 100. Turkey Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ketorolac Tromethamine Market Share by Type in 2019
Figure 107. Middle East and Africa Ketorolac Tromethamine Market Share by Application in 2019
Figure 108. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Omeros Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Egalet US Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. West Ward Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Amphastar Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Gland Pharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Sagent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. North America Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Europe Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Asia Pacific Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Latin America Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 134. Middle East and Africa Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
Figure 1. Ketorolac Tromethamine Product Picture
Figure 2. Global Ketorolac Tromethamine Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Ophthalmic Product Picture
Figure 5. Nasal Product Picture
Figure 6. Oral tablet Product Picture
Figure 7. Global Ketorolac Tromethamine Sales Market Share by Application in 2020 & 2026
Figure 8. Short-term treatment of pain
Figure 9. Ophthalmic Surgery
Figure 10. Ketorolac Tromethamine Report Years Considered
Figure 11. Global Ketorolac Tromethamine Market Size 2015-2026 (US$ Million)
Figure 12. Global Ketorolac Tromethamine Sales 2015-2026 (K Units)
Figure 13. Global Ketorolac Tromethamine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Ketorolac Tromethamine Sales Market Share by Region (2015-2020)
Figure 15. Global Ketorolac Tromethamine Sales Market Share by Region in 2019
Figure 16. Global Ketorolac Tromethamine Revenue Market Share by Region (2015-2020)
Figure 17. Global Ketorolac Tromethamine Revenue Market Share by Region in 2019
Figure 18. Global Ketorolac Tromethamine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Ketorolac Tromethamine Revenue in 2019
Figure 20. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ketorolac Tromethamine Sales Market Share by Type (2015-2020)
Figure 22. Global Ketorolac Tromethamine Sales Market Share by Type in 2019
Figure 23. Global Ketorolac Tromethamine Revenue Market Share by Type (2015-2020)
Figure 24. Global Ketorolac Tromethamine Revenue Market Share by Type in 2019
Figure 25. Global Ketorolac Tromethamine Market Share by Price Range (2015-2020)
Figure 26. Global Ketorolac Tromethamine Sales Market Share by Application (2015-2020)
Figure 27. Global Ketorolac Tromethamine Sales Market Share by Application in 2019
Figure 28. Global Ketorolac Tromethamine Revenue Market Share by Application (2015-2020)
Figure 29. Global Ketorolac Tromethamine Revenue Market Share by Application in 2019
Figure 30. North America Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 33. North America Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 34. U.S. Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Ketorolac Tromethamine Market Share by Type in 2019
Figure 39. North America Ketorolac Tromethamine Market Share by Application in 2019
Figure 40. Europe Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 43. Europe Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 44. Germany Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Ketorolac Tromethamine Market Share by Type in 2019
Figure 55. Europe Ketorolac Tromethamine Market Share by Application in 2019
Figure 56. Asia Pacific Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region in 2019
Figure 60. China Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Ketorolac Tromethamine Market Share by Type in 2019
Figure 83. Asia Pacific Ketorolac Tromethamine Market Share by Application in 2019
Figure 84. Latin America Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 87. Latin America Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 88. Mexico Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Ketorolac Tromethamine Market Share by Type in 2019
Figure 95. Latin America Ketorolac Tromethamine Market Share by Application in 2019
Figure 96. Middle East and Africa Ketorolac Tromethamine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Ketorolac Tromethamine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country in 2019
Figure 100. Turkey Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Ketorolac Tromethamine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Ketorolac Tromethamine Market Share by Type in 2019
Figure 107. Middle East and Africa Ketorolac Tromethamine Market Share by Application in 2019
Figure 108. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Omeros Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Egalet US Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. West Ward Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Amphastar Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Gland Pharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Sagent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. North America Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Europe Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Asia Pacific Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Latin America Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Ketorolac Tromethamine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 134. Middle East and Africa Ketorolac Tromethamine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
